Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Bioorganic & Medicinal Chemistry Letters|April 15, 2015
Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4William T McElroy, W Michael Seganish, R Jason Herr, et al.JCO Precision Oncology|December 6, 2024
<i>KRAS</i> Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract CancersRebecca Gelfer, Aiste Gulla, Hannah L Kalvin, et al.JCO Precision Oncology|October 23, 2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and SurvivalPratik Chandra, Yi Song, Esther Drill, et al.Bioorganic & Medicinal Chemistry Letters|June 28, 2015
Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4W Michael Seganish, William T McElroy, R Jason Herr, et al.Annals of Surgical Oncology|October 19, 2025
Outcomes of First Versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic CholangiocarcinomaNaaz Nasar, Misha Armstrong, Joanne F Chou, et al.Journal of Hepatology|June 22, 2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, et al.Hepatology (Baltimore, Md.)|March 25, 2021
Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaThomas Boerner, Esther Drill, Linda M Pak, et al.Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.Pageof 4